Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Gains from Sales and Divestitures (2023)

Historic Gains from Sales and Divestitures for 60 Degrees Pharmaceuticals (SXTP) over the last 1 years, with Q4 2023 value amounting to $256000.0.

  • 60 Degrees Pharmaceuticals' Gains from Sales and Divestitures changed N/A to $256000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $256000.0, marking a year-over-year change of. This contributed to the annual value of $256000.0 for FY2023, which is N/A changed from last year.
  • 60 Degrees Pharmaceuticals' Gains from Sales and Divestitures amounted to $256000.0 in Q4 2023.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Gains from Sales and Divestitures ranged from a high of $256000.0 in Q4 2023 and a low of $256000.0 during Q4 2023